Encompass Health (EHC) — insider trading
Health Care · NYSE
Encompass Health (EHC) has 55 reported SEC Form 4 insider transactions in our data, including 9 open-market sales among the most recent 55 (latest 2026-10-19).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-19 | Reidy Christopher R | Director | Grant / award / vesting | 284 | $126.89 | $36.0K | Form 4 |
| 2026-10-19 | Christie Edward M III | Director | Grant / award / vesting | 221 | $126.63 | $28.0K | Form 4 |
| 2026-10-15 | Williams Terrance | Director | Grant / award / vesting | 28 | — | $0 | Form 4 |
| 2026-10-15 | SCHLICHTING NANCY M | Director | Grant / award / vesting | 38 | — | $0 | Form 4 |
| 2026-10-15 | HERMAN JOAN E | Director | Grant / award / vesting | 81 | — | $0 | Form 4 |
| 2026-10-15 | Reidy Christopher R | Director | Grant / award / vesting | 20 | — | $0 | Form 4 |
| 2026-10-15 | Hayes Cain A | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-10-15 | O'Connor Kevin J. | Director | Grant / award / vesting | 18 | — | $0 | Form 4 |
| 2026-10-15 | KATZ LESLYE G | Director | Grant / award / vesting | 81 | — | $0 | Form 4 |
| 2026-10-15 | Christie Edward M III | Director | Grant / award / vesting | 11 | — | $0 | Form 4 |
| 2026-10-15 | CARMICHAEL GREG D | Director | Grant / award / vesting | 28 | — | $0 | Form 4 |
| 2026-08-31 | Price Andrew L | Officer (Chief Accounting Officer) | Open-market sale | 5,211 | $120.93 | $630.2K | Form 4 |
| 2026-08-31 | Darby John Patrick | Officer (EVP, Gen Counsel & Secretary) | Option exercise / conversion (derivative) | 4,858 | — | $0 | Form 4 |
| 2026-08-31 | Darby John Patrick | Officer (EVP, Gen Counsel & Secretary) | Open-market sale | 4,858 | $121.09 | $588.3K | Form 4 |
| 2026-08-31 | Darby John Patrick | Officer (EVP, Gen Counsel & Secretary) | Option exercise / conversion | 4,858 | $35.06 | $170.3K | Form 4 |
| 2026-08-10 | Darby John Patrick | Officer (EVP, Gen Counsel & Secretary) | Open-market sale | 8,906 | $125.95 | $1.12M | Form 4 |
| 2026-08-10 | Tarr Mark J | Director, Officer (President & CEO) | Open-market sale | 1,579 | $126.06 | $199.0K | Form 4 |
| 2026-08-10 | Tarr Mark J | Director, Officer (President & CEO) | Open-market sale | 171,569 | $125.46 | $21.53M | Form 4 |
| 2026-08-10 | COLTHARP DOUGLAS E | Officer (EVP & Chief Financial Officer) | Open-market sale | 18,869 | $125.38 | $2.37M | Form 4 |
| 2026-07-16 | Christie Edward M III | Director | Grant / award / vesting | 248 | $112.43 | $27.9K | Form 4 |
| 2026-07-16 | Reidy Christopher R | Director | Grant / award / vesting | 319 | $112.40 | $35.9K | Form 4 |
| 2026-07-15 | CARMICHAEL GREG D | Director | Grant / award / vesting | 29 | — | $0 | Form 4 |
| 2026-07-15 | Hayes Cain A | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-07-15 | HERMAN JOAN E | Director | Grant / award / vesting | 85 | — | $0 | Form 4 |
| 2026-07-15 | KATZ LESLYE G | Director | Grant / award / vesting | 85 | — | $0 | Form 4 |
| 2026-07-15 | O'Connor Kevin J. | Director | Grant / award / vesting | 19 | — | $0 | Form 4 |
| 2026-07-15 | SCHLICHTING NANCY M | Director | Grant / award / vesting | 40 | — | $0 | Form 4 |
| 2026-07-15 | Williams Terrance | Director | Grant / award / vesting | 29 | — | $0 | Form 4 |
| 2026-07-15 | Christie Edward M III | Director | Grant / award / vesting | 11 | — | $0 | Form 4 |
| 2026-07-15 | Reidy Christopher R | Director | Grant / award / vesting | 21 | — | $0 | Form 4 |
| 2026-05-15 | COLTHARP DOUGLAS E | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 27,694 | — | $0 | Form 4 |
| 2026-05-15 | COLTHARP DOUGLAS E | Officer (EVP & Chief Financial Officer) | Open-market sale | 1 | $107.28 | $107 | Form 4 |
| 2026-05-15 | COLTHARP DOUGLAS E | Officer (EVP & Chief Financial Officer) | Open-market sale | 27,693 | $106.83 | $2.96M | Form 4 |
| 2026-05-15 | COLTHARP DOUGLAS E | Officer (EVP & Chief Financial Officer) | Option exercise / conversion | 27,694 | $32.94 | $912.2K | Form 4 |
| 2026-05-11 | Tuer Patrick William | Officer (EVP, Chief Operating Officer) | Open-market sale | 682 | $104.56 | $71.3K | Form 4 |
| 2026-05-07 | SCHLICHTING NANCY M | Director | Grant / award / vesting | 1,634 | — | $0 | Form 4 |
| 2026-05-07 | HERMAN JOAN E | Director | Grant / award / vesting | 1,634 | — | $0 | Form 4 |
| 2026-05-07 | KATZ LESLYE G | Director | Grant / award / vesting | 1,634 | — | $0 | Form 4 |
| 2026-05-07 | Williams Terrance | Director | Grant / award / vesting | 1,634 | — | $0 | Form 4 |
| 2026-05-07 | CARMICHAEL GREG D | Director | Grant / award / vesting | 1,634 | — | $0 | Form 4 |
| 2026-05-07 | Hayes Cain A | Director | Grant / award / vesting | 1,634 | — | $0 | Form 4 |
| 2026-05-07 | Reidy Christopher R | Director | Grant / award / vesting | 1,634 | — | $0 | Form 4 |
| 2026-05-07 | Christie Edward M III | Director | Grant / award / vesting | 1,634 | — | $0 | Form 4 |
| 2026-05-07 | O'Connor Kevin J. | Director | Grant / award / vesting | 1,634 | — | $0 | Form 4 |
| 2026-04-16 | Reidy Christopher R | Director | Grant / award / vesting | 334 | $106.48 | $35.6K | Form 4 |
| 2026-04-16 | Christie Edward M III | Director | Grant / award / vesting | 261 | $106.17 | $27.7K | Form 4 |
| 2026-04-15 | Williams Terrance | Director | Grant / award / vesting | 27 | — | $0 | Form 4 |
| 2026-04-15 | SCHLICHTING NANCY M | Director | Grant / award / vesting | 39 | — | $0 | Form 4 |
| 2026-04-15 | Reidy Christopher R | Director | Grant / award / vesting | 19 | — | $0 | Form 4 |
| 2026-04-15 | O'Connor Kevin J. | Director | Grant / award / vesting | 17 | — | $0 | Form 4 |
| 2026-04-15 | KATZ LESLYE G | Director | Grant / award / vesting | 85 | — | $0 | Form 4 |
| 2026-04-15 | HERMAN JOAN E | Director | Grant / award / vesting | 85 | — | $0 | Form 4 |
| 2026-04-15 | Hayes Cain A | Director | Grant / award / vesting | 1 | — | $0 | Form 4 |
| 2026-04-15 | Christie Edward M III | Director | Grant / award / vesting | 9 | — | $0 | Form 4 |
| 2026-04-15 | CARMICHAEL GREG D | Director | Grant / award / vesting | 27 | — | $0 | Form 4 |
Ask the chat about EHC's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Encompass Health (EHC).
Last updated 2026-10-19 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.